Sodium-glucose cotransporter 2 (SGLT2) inhibitors exert both hypoglycemic and diuretic effects by inhibiting the absorption of both sodium and glucose from the proximal tubules in the kidney. Patients usually report that SGLT2i medications increase urinary volume.